Managing the Risks of Million-Dollar Therapies

Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzManagement of ultra–high-cost (UHC) pharmaceuticals such as gene and cell therapies requires active involvement from all key stakeholders to ensure best patient outcomes and financial returns, according to a session at the ASHP Midyear 2025 Clinical Meeting & Exhibition, in Las Vegas.The presenters emphasized the important role pharmacists play in every step of the process, from cell collection to a